收藏切换
Study on the effect of vedolizumab on ulcerative colitis and its mechanism of action on mitochondrial autophagy
收藏切换
Bin TIAN1a, Shan YANG1b, Zhipeng FENG2, *
World Clinical Drug | 2025, 46(12) : 1249 - 1254
Less
收藏切换
World Clinical Drug | 2025, 46(12): 1249-1254
• Article •
Study on the effect of vedolizumab on ulcerative colitis and its mechanism of action on mitochondrial autophagy
Full
Bin TIAN1a, Shan YANG1b, Zhipeng FENG2, *
Affiliations
  • 1a. Department of General Surgery, Fenyang Hospital of Shanxi Province, Fenyang Hospital Affiliated to Shanxi Medical University, Fenyang 032200, Shanxi Province, China
  • 1b.Department of Anesthesiology, Fenyang Hospital of Shanxi Province, Fenyang Hospital Affiliated to Shanxi Medical University, Fenyang 032200, Shanxi Province, China
  • 2.Department of Gastroenterology, Taiyuan Central Hospital, Taiyuan 030009, Shanxi Province, China
Published: 2025-12-10 doi: 10.13683/j.wph.2025.12.008
Outline
收藏切换
Objective

To explore the effect of vedolizumab in the treatment of ulcerative colitis(UC) and its mechanism of action on mitochondrial autophagy.

Methods

A total of 96 patients with UC admitted to our hospital from January 2021 to December 2024 were selected as the research subjects. They were divided into the observation group and the control group by simple sorting random method, with 48 cases in each group. By the end of the study, the two groups had dropped to the observation group with 46 cases and the control group with 45 cases. The control group was treated with mesalazine enteric-coated tablets, while the observation group was added with vedolizumab. The treatment courses for both groups were 8 weeks. After treatment, the clinical efficacy, mitochondrial autophagy, inflammatory factors, intestinal mucosal barrier function and clinical symptom scores of the two groups were compared.

Result

After treatment, the total effective rate of the observation group was higher than that of the control group(82.61% vs 62.22%, P<0.05). After treatment, the levels of PTEN-induced putative kinase(PINK)1 and parkinin in both groups were compared with those before treatment(P<0.05), and those in the observation group were higher than those in the control group(P<0.05). After treatment, the levels of tumor necrosis factor-α, interleukin(IL)-17 and IL-23 in both groups were lower than those before treatment(P<0.05), and those in the observation group were lower than those in the control group(P<0.05). After treatment, the levels of D-lactic acid, diamine oxidase and endothelin in both groups were lower than those before treatment(P<0.05), and those in the observation group were lower than those in the control group(P<0.05). By the end of the treatment, the scores of abdominal pain, diarrhea, mucus and bloody stool, and the total score in the observation group were all lower than those in the control group(P<0.05).

Conclusion

Vedilizumab treatment has a good effect on UC, which can increase the contents of PINK1 and paraquin in patients and reduce the levels of inflammatory factors.

vidalizumab  /  ulcerative colitis  /  mitochondrial autophagy  /  PTEN-induced hypothetical kinase  /  Parkin protein  /  inflammatory factor
田彬, 杨珊, 冯志鹏. 维得利珠单抗对溃疡性结肠炎效果及对线粒体自噬作用机制研究. 世界临床药物, 2025 , 46 (12) : 1249 -1254 . DOI: 10.13683/j.wph.2025.12.008
Bin TIAN, Shan YANG, Zhipeng FENG. Study on the effect of vedolizumab on ulcerative colitis and its mechanism of action on mitochondrial autophagy[J]. World Clinical Drug, 2025 , 46 (12) : 1249 -1254 . DOI: 10.13683/j.wph.2025.12.008
Year 2025 volume 46 Issue 12
43
11
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.12.008
  • Receive Date:2025-07-12
  • Online Date:2026-11-09
  • Published:2025-12-10
Article Data
Affiliations
History
  • Received:2025-07-12
Affiliations
    1a. Department of General Surgery, Fenyang Hospital of Shanxi Province, Fenyang Hospital Affiliated to Shanxi Medical University, Fenyang 032200, Shanxi Province, China
    1b.Department of Anesthesiology, Fenyang Hospital of Shanxi Province, Fenyang Hospital Affiliated to Shanxi Medical University, Fenyang 032200, Shanxi Province, China
    2.Department of Gastroenterology, Taiyuan Central Hospital, Taiyuan 030009, Shanxi Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.12.008
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT